A. Kieltyka

发表

Design and synthesis of [(2,3-dichlorophenyl)piperazin-1-yl]alkylfluorenylcarboxamides as novel ligands selective for the dopamine D3 receptor subtype.

A. Newman, S. Husbands, A. Thurkauf, 2001, Journal of medicinal chemistry.

Identification and Characterization of NDT 9513727 [N,N-bis(1,3-Benzodioxol-5-ylmethyl)-1-butyl-2,4-diphenyl-1H-imidazole-5-methanamine], a Novel, Orally Bioavailable C5a Receptor Inverse Agonist

J. Krause, M. E. Buck, R. Brodbeck, 2008, Journal of Pharmacology and Experimental Therapeutics.

Design, synthesis, and discovery of 3-piperazinyl-3,4-dihydro-2(1H)-quinolinone derivatives: a novel series of mixed dopamine D2/D4 receptor antagonists.

H. Zhao, A. Thurkauf, A. Kieltyka, 2000, Bioorganic & medicinal chemistry letters.

Identification and characterization of NDT 9513727, a novel, orally bioavailable C5a receptor inverse agonist

J. Krause, M. E. Buck, R. Brodbeck, 2008 .

1H-Pyrazolo-[3,4-c]cyclophepta[1,2-c]thiophenes: a unique structural class of dopamine D4 selective ligands.

W. Greenlee, Suoming Zhang, A. Ganguly, 2003, Bioorganic & medicinal chemistry letters.

Indoline and piperazine containing derivatives as a novel class of mixed D(2)/D(4) receptor antagonists. Part 1: identification and structure-activity relationships.

K. Hodgetts, R. Brodbeck, S. Rachwał, 2002, Bioorganic & medicinal chemistry letters.

6-(4-Benzylpiperazin-1-yl)benzodioxanes as selective ligands at cloned primate dopamine D(4) receptors.

K. Hodgetts, R. Brodbeck, A. Thurkauf, 2001, Bioorganic & medicinal chemistry.

Design, synthesis, and discovery of 5-piperazinyl-1,2,6,7-tetrahydro-5H-azepino[3,2,1-hi]indol-4-one derivatives: a novel series of mixed dopamine D2/D4 receptor antagonist.

J. Chandrasekhar, K. Hodgetts, R. Brodbeck, 2003, Bioorganic & medicinal chemistry letters.

3-Aryl pyrazolo[4,3-d]pyrimidine derivatives: Nonpeptide CRF-1 antagonists.

S. De Lombaert, K. Hodgetts, R. Brodbeck, 2002, Bioorganic & medicinal chemistry letters.

Indoline and piperazine containing derivatives as a novel class of mixed D(2)/D(4) receptor antagonists. Part 2: asymmetric synthesis and biological evaluation.

He Zhao, D. Hoffman, R. Brodbeck, 2002, Bioorganic & medicinal chemistry letters.

Discovery of N-(1-ethylpropyl)-[3-methoxy-5-(2-methoxy-4-trifluoromethoxyphenyl)-6-methyl-pyrazin-2-yl]amine 59 (NGD 98-2): an orally active corticotropin releasing factor-1 (CRF-1) receptor antagonist.

Ping Ge, Taeyoung Yoon, Dario Doller, 2011, Journal of medicinal chemistry.

trans-1-[(2-Phenylcyclopropyl)methyl]-4-arylpiperazines: mixed dopamine D(2)/D(4) receptor antagonists as potential antipsychotic agents.

D. Hoffman, H. Zhao, K. Hodgetts, 2000, Journal of medicinal chemistry.

Indoline and Piperazine Containing Derivatives as a Novel Class of Mixed D2/D4 Receptor Antagonists. Part 2. Asymmetric Synthesis and Biological Evaluation.

D. Hoffman, R. Brodbeck, A. Thurkauf, 2003 .